Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00086645 · ClinicalTrials.gov registry record · Phase 2

Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)

A Phase 2 study of Autistic Disorder, sponsored by Boston University.

Completed
Registry status
Phase 2
Development phase
149
Enrollment target
6
Study locations

NCT00086645 is a Phase 2 study of Autistic Disorder that has completed, run by Boston University. The registered enrollment target is 149 participants, above the 108-participant average among 27 other Autistic Disorder trials with a reported enrollment target (38% higher). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00086645, a Phase 2 study of Autistic Disorder, has completed, sponsored by Boston University.

COMPLETED
Registry status
Phase 2
Development phase
149 participants
Enrollment target
6
Study locations

Study Summary

This study will determine the efficacy and safety of citalopram compared to placebo in the treatment of children with autism.

Conditions Studied

Autistic Disorder

Interventions

  • OTHER placebo
  • DRUG citalopram hydrobromide

Study Locations (6)

New York

  • North Shore - Long Island Jewish Hospital - Great Neck
  • Mount Sinai School of Medicine - New York

California

  • UCLA Neuropsychiatric Institute - Los Angeles

Connecticut

  • Yale University - New Haven

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

North Carolina

  • University of North Carolina Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2004-04
Est. Completion 2007-04
Phase Phase 2

Sponsor

Boston University

185 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00086645

The ClinicalTrials.gov registry entry for NCT00086645 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 108-participant average among 27 other Autistic Disorder trials with a reported enrollment target (38% higher). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autistic Disorder appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00086645 reports 6 study locations spanning 5 distinct geographic areas - top geographies include New York, California, Connecticut.

Frequently Asked Questions

What is clinical trial NCT00086645 about?

NCT00086645 is a clinical study titled "Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)". This study will determine the efficacy and safety of citalopram compared to placebo in the treatment of children with autism.

What is the current status of trial NCT00086645?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 149 participants. The study started on 2004-04. Estimated completion is 2007-04.

What conditions does trial NCT00086645 study?

This clinical trial studies the following conditions: Autistic Disorder.

What interventions are being tested in trial NCT00086645?

The interventions under investigation include: placebo (OTHER), citalopram hydrobromide (DRUG).

Who is sponsoring clinical trial NCT00086645?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00086645 being conducted?

This trial has 6 study locations across California, Connecticut, New Hampshire, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autistic Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autistic Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.